The National Institute for Health and Care Excellence (Nice) said it is "extremely disappointed" it will be unable to ...

Our price target for 2026 is $136.62. The new obesity drug CagriSema is presently near completion of FDA phase-2 trials.

“He’s got an uphill climb,” Sen. Joni Ernst, R-Iowa, told the outlet.

Therefore, incorporating cosmetic medicine as a part of employee benefit programs is attracting attention as an initiative ...

Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Artificial intelligence is making impressive strides in its ability to read medical images. In a recent test in Britain's ...

A 35-year-old veterinarian took his own life after enduring significant stress in both his personal and professional life. Dr ...